Article | July 25, 2017

A Paradigm Shift In Container Closure Integrity Of Parenteral Drugs

Source: PTI Packaging and Inspection Systems

By Oliver Stauffer, CEO , PTI Inspection

MicroCurrent HVLD

If there is a leak or breach of the sterile barrier, environmental contaminants can rapidly convert a life-saving treatment into a microbial soup. The latest evolution of HVLD, PTI’s patent pending MicroCurrent technology, aims to achieve a high level of CCI assurance across the entire range of parenteral products.

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

PTI Packaging and Inspection Systems